Search

The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22
Authors
Wang, X., Gupta, A.K., Prakash, P., Putkey, J.P., Gorfe, A.A.
Assembly
GTPase KRas
Entity
1. GTPase KRas, entity 1 (polymer, Thiol state: all free), 169 monomers, 19245.52 Da Detail

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK


2. GTPase KRas, entity GDP (non-polymer), 443.201 Da
3. GTPase KRas, entity MG (non-polymer), 24.305 Da
4. GTPase KRas, entity QPD (non-polymer), 308.335 Da
Total weight
20021.361 Da
Max. entity weight
19245.52 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 95.3 %, Completeness: 30.7 %, Completeness (bb): 65.9 % Detail

Polymer type: polypeptide(L)

Total1H15N
All30.7 % (369 of 1201)20.3 % (208 of 1023)90.4 % (161 of 178)
Backbone65.9 % (336 of 510)50.7 % (175 of 345)97.6 % (161 of 165)
Sidechain 4.8 % (33 of 691) 4.9 % (33 of 678) 0.0 % (0 of 13)
Aromatic 0.0 % (0 of 70) 0.0 % (0 of 70)
Methyl10.5 % (10 of 95)10.5 % (10 of 95)

1. entity 1

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK

Sample #1

Solvent system 95% H2O/5% D2O, Pressure 1 Pa, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] KRAS, 1.0 mM E22, 5 mM [U-99% 2H] DTT, 10 uM [U-99% 2H] DSS, 25 mM nature abundance sodium phosphate, 50 mM sodium chloride, 5 mM MAGNESIUM ION, 95% H2O/5% D2O


#NameIsotope labelingTypeConcentration
1KRAS[U-99% 13C; U-99% 15N]0.8 mM
2E22natural abundance1.0 mM
3DTT[U-99% 2H]5 mM
4DSS[U-99% 2H]10 uM
5sodium phosphatenature abundance25 mM
6sodium chloridenatural abundance50 mM
7MAGNESIUM IONnatural abundance5 mM
Sample #2

Solvent system 100% D2O, Pressure 1 Pa, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] KRas, 1.0 mM E22, 5 mM [U-99% 2H] DTT, 10 uM [U-99% 2H] DSS, 25 mM sodium phosphate, 50 mM sodium chloride, 5 mM MAGNESIUM ION, 100% D2O


#NameIsotope labelingTypeConcentration
8E22natural abundance1.0 mM
9DTT[U-99% 2H]5 mM
10DSS[U-99% 2H]10 uM
11sodium phosphatenatural abundance25 mM
12sodium chloridenatural abundance50 mM
13MAGNESIUM IONnatural abundance5 mM
14KRas[U-99% 13C; U-99% 15N]0.8 mM

Protein Blocks Logo
Calculated from 10 models in PDB: 6V5L, Strand ID: A Detail


Release date
2019-12-09
Citation
Multi-target, ensemble-based virtual screening yields novel allosteric KRAS inhibitors at high success rate
Gupta, A.K., Wang, X., Pagba, C.V., Prakash, P., Putkey, J.P., Gorfe, A.A.
Chem. Biol. Drug Des. (2019), 94, 1441-1456, PubMed 30903639 , DOI 10.1111/cbdd.13519 ,
Related entities 1. GTPase KRas, entity 1, : 1 : 24 : 5 : 74 : 195 entities Detail
Interaction partners 1. GTPase KRas, entity 1, : 53 interactors Detail
Experiments performed 9 experiments Detail
Chemical shift validation 6 contents Detail
Keywords HADDOCK, KRas, Signaling Protein-Inhibitor complex, TRANSFERASE-TRANSFERASE inhibitor complex, allosteric inhibitor, drug discovery